P.1.005 - Mutating the cholesterol binding site on amyloid precursor protein alters the processing and production of Aβ-amyloid peptides

Abstract

Levels of cholesterol are elevated in the brains of Alzheimer’s disease (AD) patients [1,2]. While the precise pathophysiological consequences remain unclear, an increase in cholesterol at the plasma membrane promotes endocytosis of the amyloid precursor protein (APP) thereby leading to increased Aβ production [3]. An interaction between the Aβ fragment C99 (resulting from cleavage of APP by β-secretase), and cholesterol was recently proposed [4]. In the present work, we studied the nature of this putative cholesterol binding site (CBS) on APP by analyzing APP mutants within the CBS (located between 691-710 of APP770). We measured the influence of mutants on production of amyloid peptides, cleavage by secretases and the subcellular localization of APP mutants in HEK293T cells. A variety of mutants of the CBS of APP751-mCherry (APP isoform which contain 751 residues fused to the fluorescent protein mCherry) were constructed using site-directed mutagenesis: E693K, S697A, K699A, K699E, G700A, G704A, V710A, S697A/K699A and G700A/G704A (numbering according to APP770 sequence). The amounts of secreted Aβ40 and Aβ42 peptides were measured by ELISA (Meso Scale Discovery) and short peptides (28 to 42aa) by ELISA from IBL (Immuno-Biological Laboratories) in the culture medium of HEK293T cells transfected with various mutants. We studied the activity of secretases by analyzing the levels of C99 and AICD (APP Intracellular Domain) using western blot. In addition, we analyzed the subcellular localization of mutant APP-mCherry by confocal microscopy, using immunocytochemistry with anti-Early Endosome Antigen 1 antibodies. Levels of secreted Aβ40 and Aβ42 were significantly decreased in HEK293T cells transfected with all mutants (except for S697A) as compared to HEK293T cells transfected with APPwt (p In conclusion, these results suggest that the CBS is a key player in the processing of APP and generation of neurotoxic fragments like Aβ42. Further, a specific interaction between cholesterol and the APP CBS controls the size as well as amount of Aβ peptides. We hypothesize that CBS mutants are positioned more deeply in the membrane thus being processed differently leading to the formation of shorter Aβ peptides. These data demonstrate the functional importance of an interaction between cholesterol and APP, provide insights into the pathology of AD, and suggest potential routes to novel therapies.